| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |